Is to ensure all Canadian patients who benefit from medical marijuana, have access to the highest quality of product and services, to meet their specific health care needs in a safe, well-regulated environment.
As a united community, the Canadian National Medical Marijuana Association (CNMMA) seeks to:
Advocate for the sector
The new program- like all new programs – will go through challenges and barriers including unintended consequences of the regulations. As a community, the members of the CNMMA will have an official voice to work with governments to ensure the sector has the parameters to be successful.
Guide patients and educate Canadians
While the CNMMA cannot provide medical advice to patients, it can help patients understand the new program. Most Canadians are receiving information on the new Marijuana for Medical Purposes Regulations from the media. The CNMMA will provide Canadians with the most current information on medicinal marijuana, the program, and the research to become well-informed consumers.
Be a resource for medical practitioners
As much as the program is new for patients, it is new for the medical community as well. Medical practitioners can benefit from sharing resources, studies, and data – with the Association providing a sharing forum.
While medical marijuana is purely focused on helping patients, it is an illicit substance for recreational use in Canada. Therefore, it is necessary to put efforts in ensuring the medical marijuana has a strong reputation, putting patients front and centre, and contributing to a stronger health care system.
Share best practices
When all parties contribute to a stronger sector, everyone benefits. The CNMMA will work towards sharing best practices to help build the sector as a whole.
Be a resource to Health Canada
While the new system minimizes Health Canada’s role, the government of Canada will seek to ensure the new program is meeting the needs of patients in Canada. The CNMMA will assist in providing the essential date and information for Health Canada to properly evaluate the progress of the new program.
Therapeutic Potential of Cannabis
Cannabinoids for Non Cancer Pain
Cannabinoids in Palliative Care
Evaluation of quality of medicinal grade cannabis in Netherlands
Recent Clinical Trials (2005-2009)
Clinical Studies and Cases
Link to Recent Research on Medical Marijuana article on the NORML (Working to reform the marijuana laws)
Visualization of the endocannabinoid signaling system
Health Canada Drug Product Monograph
Cannabis Induces a Clinical Response in Patients With Crohn’s Disease: A Prospective Placebo-Controlled Study
Prescribing cannabis for harm reduction.
Center for Medicinal Cannabis Research Scientific Publications.
Effects of Marijuana Smoking on the Lung.
Hypothesizing that marijuana smokers are at a significantly lower risk of carcinogenicity relative to tobacco-non-marijuana smokers
Marijuana and lung diseases.
Marijuana Use and the Risk of Lung and Upper Aero digestive tract cancers: Results of a Population-Based Case-Control Study
- Government relations professionals and communications experts representing the membership
- High quality skilled labour through job matching/posts only accessible to members
- Resources and clinical information on the ever increasing evidence of the benefits of medical marihuana
- Information to support medical health professionals so they may prescribe with confidence
- Much more, click below to learn more